Tanogitran

DB21367InvestigationalSmall molecule

Tanogitran is a small molecule drug. Tanogitran is under investigation in clinical trial NCT02254057 (Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects). Tanogitran has... Tanogitran has a monoisotopic molecular weight of 477.25 Da.

Formula / weight: C₂₅H₃₁N₇O₃ · 477.569 g/mol (avg)
Code names: BIBT-986 · BIBT-986-BS

Resolves to

Compound

UNIIX5QRR6Z56QCAS637328-69-9ChEMBLCHEMBL1270156ChEBI749742PubChem9826322

Structure

InChIKeyMAOALPSHCIBFJZ-RUZDIDTESA-NSMILESCN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=CC(=CC=C12)[C@@](C)(NCC(O)=O)C(=O)N1CCCC1

Targets

P00742F10

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Tanogitran, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account